Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11510990 Conjugates of fusion proteins of GLP-1 and FGF21

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
September 26, 2021
Date of Patent
November 29, 2022
Patent Application Number
17485424
Patent Citations
‌
US Patent 10138291 Factor VIII complex with XTEN and von Willebrand Factor protein, and uses thereof
‌
US Patent 10172953 XTEN conjugate compositions and methods of making same
‌
US Patent 10407479 Mutant FGF-21 peptide pegylated conjugates and uses thereof
‌
US Patent 10413590 Methods of using compositions comprising variants of FGF19 polypeptides for reducing body mass in a subject
‌
US Patent 10421798 Factor VIII compositions and methods of making and using same
‌
US Patent 10583174 FGF21 compound / GLP-1R agonist combinations with optimized activity ratio
‌
US Patent 10548953 Factor VIII-XTEN fusions and uses thereof
‌
US Patent 10669323 Methods of treating metabolic disorders with dual function fibroblast growth factor 21 proteins
‌
US Patent 10035839 Blood glucose lowering compound
‌
US Patent 10124039 FGF21 derivatives and uses thereof
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11510990
Patent Primary Examiner
‌
Lianko G Garyu

Find more entities like US Patent 11510990 Conjugates of fusion proteins of GLP-1 and FGF21

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo